Teva betting on Schultz as CEO with $40m package
Dane lands top job with beleaguered generics giant after reviving Lundbeck’s fortunes
Drug firm Teva predicts 2017 revenue and profit below estimates
Israel company expects earnings per share of $4.90-$5.30 on revenue of $23.8bn-$24.5bn
Teva completes acquisition of Allergan’s generics business
Pharmaceutical acquisition was announced a year ago with $40.5bn price tag
Drug firm Perrigo buys OTC portfolio of drugs from GSK
Bolt-on acqusition strengthens position in Europe amid three-way takeover battle
Generic drugmaker Teva makes $40bn offer for rival Mylan
Mylan adopts poison-pill defence and renews commitment to Perrigo deal
Teva to buy Auspex Pharmaceuticals in $3.5 billion deal
Firm bolsters its business of making drugs to treat disease of the central nervous system
Generics will not cut medicine bill, says Teva chief
Demand will create ‘inexorable upward pressure’ despite efforts by minister to cut the costs
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices